药品专利保护与药品费用负担——基于27个国家和地区的数据分析  

Empirical Research on Relationship between Pharmaceutical Patent Protection and Drug Expenditure——Based on the Analysis of 27 Sample Countries and Regions

作　　者：姚颉靖[1,2] 彭辉[2] 

机构地区：[1]上海政法学院法律系,上海201701 [2]同济大学知识产权学院,上海200433

出　　处：《华南农业大学学报（社会科学版）》2010年第3期66-71,共6页Journal of South China Agricultural University(Social Science Edition)

基　　金：上海市社科规划青年课题项目(2006EZH002);国家建设高水平大学公派研究生项目(2007102344)

摘　　要：在医药技术、医药经济和公共健康倍受关注的今天,药品专利保护的双面刃性质已成为国内外学界和产业界关注的焦点。文章对27个国家和地区的药品专利保护与药品费用负担的关系进行了实证分析,结果显示,药品专利保护随着药品费用负担增加起初降低然后提高,两者呈U型关系,此拐点的人均药品费用支出为86.67美元,药品专利保护强度为2.738。Nowadays, medical technology, medical economy and public health have drawn more attention. The character of pharmaceutical patent protection, i.e. double-edged sword nature, has become the focus of domestic and foreign academic circle and industry. This paper made empirical analysis of the relationship between pharmaceutical patent protection and drug expenditure based on dates from 27 countries and regions. The analysis outcome revealed that the patent protection level for pharmaceutical products decreases with the rising level of drug expenditure first, and then increases. The relationship between pharmaceutical patent protection and drug expenditure forms a U-shape, the inflection point of drug expenditure per capita is 86.67 U.S. dollars, and strength of pharmaceutical patent protection 2. 738.

关 键 词：药品专利保护 药品费用负担 最优值 

分 类 号：D923.42[政治法律—民商法学] F763[政治法律—法学]